• About us
• Contact

Advertisement

Organisation › Details

Nuclea Biotechnologies Inc.

Nuclea Biotechnologies, Inc. is headquartered in Pittsfield, Massachusetts with additional operations in Worcester and Cambridge, Massachusetts. Nuclea has developed and is commercializing unique diagnostic tests for colon, breast, leukemia, lung, and prostate cancer, as well as for diabetes and other metabolic syndromes. Nuclea also performs research leading to novel molecular oncology companion diagnostics for the pharmaceutical and biotechnology industries. *

 

	Start	2005-04-01 established
	End	2016-08-30 bankruptcy filed
	Industry	diagnostics (medical/biological)
	Industry 2	mass spectrometry (MS)
	Person	Muraca, Patrick J. (Nuclea Biotechnologies 201309 CEO)
	Person 2	Lopez, Mary F. (Nuclea Biotechnologies 201502– COO before Thermo Fisher BRIMS + PerkinElmer + Proteome Systems)
	Street	105 South Street
	City	01201 Pittsfield, MA
	Tel	+1-413-749-4705
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.